Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Forest
 More »

  • Forest Labs Bets Up To $460M on Trevena Heart Failure Drug
    Forest Laboratories will join Trevena in developing its clinical-stage acute heart failure ... Under the deal, Forest Labs will make a $30 million investment in Trevena, and could pay ...
    5-9-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... 2012 sales: $12.2 million 6 Marketer(s): Forest Laboratories Indication(s): Long-term ... Marketer(s): Ironwood Pharmaceuticals and Forest Laboratories Indication(s): Irritable ...
    4-4-2013
  • On the Menu: Supersized Soda Wars
    translate into easier passage for the soda law," Rogan Kersh, Ph.D., provost and professor of political science at Wake Forest University, told GEN. New York City, Dr. ...
    3-22-2013
  • The Albatross Project
    An albatross, to be precise. You'll find all things albatross on the website for The Albatross Project of Wake Forest University. The research question deals with understanding ...
    2-15-2013
  • Novartis Ends Nicotine Addiction Vaccine Project
    However, all is not lost for the vaccine yet: in November of 2010, Duke University, in collaboration with Wake Forest University, commenced a Phase II clinical pharmacokinetic/...
    1-23-2013
  • SeraCare Sheds Biorepository Assets, Focuses on IVD
    He previously served as co-founder of Life Sciences Group, and CEO and CTO of Protein Forest, and earlier held executive R&D positions with PerkinElmer Life Sciences and DuPont NEN ...
    1-4-2013
  • People in the News
    Before joining Shire, Dr. Jonas served as evp at Isis Pharmaceuticals. Prior to this, Jeff was CMO and evp at Forest Laboratories. Arrowhead Research appointed Robert G. Gish, M.D. ...
    1-1-2013
  • Fixed-Dosed Drug Combination for Alzheimer's
    Forest Laboratories and Adamas Pharmaceuticals entered into an agreement for the ... Under the agreement, Forest and Adamas will collaborate on the development of the FDC, and ...
    11-14-2012
  • Lucky 13 Serial Entrepreneurs
    ... Degrees: Wake Forest University, B.A. in Chemistry and Biology; Ph.D. in Biochemistry; honorary doctorate. Linda Rhodes, V.M.D., Ph.D Aratana Therapeutics -Founding CEO; currently ...
    11-12-2012
  • Top 20 Molecular Millionaires
    ... on Sept. 27, 2012, from A$33.06] #11. Howard Solomon Chairman, President, and CEO, Forest Laboratories Total value of common shares owned: $31,058,871.48 929,628 common shares ...
    9-28-2012
  • Funding for Stem Cell Treatment of Compartment Syndrome
    technology in combination with the Wake Forest Institute of Regenerative Medicine's ... technology in combination with the Wake Forest Institute of Regenerative Medicine's ...
    9-17-2012
  • EC Clears Antibiotic Effective Against MRSA
    co-exclusive development rights to ceftaroline fosamil from Forest Laboratories in 2009. The drug was launched by Forest in the U.S. under the tradename Teflaro® in March 2011. ...
    8-29-2012
  • Citizen Groups Take Scientific Research Out of the Laboratory...
    ... the scientists are often so zeroed in on one particular aspect of a disease that they don't see the scientific forest for the trees. I believe citizen scientists are here to stay. ...
    8-23-2012
  • Top 25 Biotech Companies
    ... Cap: $6.84 billion (6/30: 179.5 million shares * price €30.99) % Change: 28.2% #13. Forest Laboratories 2012 Market Cap: $8.87 billion (8/8: 265,693,834 shares * price $33.40) ...
    8-17-2012
  • FDA Approves Tudorza Pressair for COPD
    Forest Laboratories is distributing the drug in the U.S. under a license with Barcelona, ... Forest expects Tudorza Pressair to be available to wholesalers in the fourth quarter. ...
    7-24-2012
  • More »

    Journal Articles

  • Hantaviruses and Their Hosts in Europe: Reservoirs Here and There...
    Gert E. Olsson, Herwig Leirs, Heikki Henttonen
    Vector-Borne and Zoonotic Diseases
    The spatial distribution of hantaviruses further depends on parameters such as forest patch size and connectivity of the most suitable rodent habitats, and the conditions for the ...
  • Prevalence of Five Pathogenic Agents in Questing Ixodes ricinus...
    Violaine Cotté, Sarah Bonnet, Martine Cote, Muriel Vayssier-Taussat
    Vector-Borne and Zoonotic Diseases
    the two forests, with a higher prevalence of B. burgdorferi sl in ticks from the forest of Princé and a higher prevalence of Babesia sp. in ticks from the forest of Gâvre. ...
  • Spatial and Temporal Patterns of Human African Trypanosomosis...
    P. Grébaut, J.A. Mbida Mbida, C. Antonio Kondjio, F. Njiokou, L. Penchenier, C. Laveissiére
    Vector-Borne and Zoonotic Diseases
    Risk in the Bipindi Focus, in the Forest Zone of Southern Cameroon Vector-Borne ... risk index was used in the HAT focus of Bipindi, in the forest zone of southern Cameroon. ...
  • Questing Ticks in Suburban Forest Are Infected by at Least Six...
    Caroline Reis, Martine Cote, Richard E.L. Paul, Sarah Bonnet
    Vector-Borne and Zoonotic Diseases
    Questing Ticks in Suburban Forest Are Infected by at Least Six Tick-Borne Pathogens Vector-Borne and Zoonotic Diseases Abstract The role of Ixodes ricinus ticks in the transmission ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll